Medicare Enrolled

Dr. Ricardo Alvarez, MD

Medical Oncology · Houston, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Speaking/Promotional
925 GESSNER RD STE 600, Houston, TX 77024
7138279525
In practice since 2008 (18 years)
NPI: 1649441601 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Alvarez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alvarez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Alvarez

Dr. Ricardo Alvarez is a medical oncology in Houston, TX, with 18 years in practice. Based on federal Medicare data, Dr. Alvarez performed 624 Medicare services across 184 unique beneficiaries.

Between the years covered by Open Payments, Dr. Alvarez received a total of $465,495 from 72 pharmaceutical and/or device companies across 772 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Alvarez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice▲ 624 Medicare services$ $465,495 industry payments

Medicare Practice Summary

Medicare Utilization ↗
624
Medicare services
Bottom 41% in TX for medical oncology
184
Unique beneficiaries
$50
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~35 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Complete blood count (CBC) with differential147$8$23
Office visit, established patient (30-39 min)127$95$395
Administration of chemotherapy into vein, 1 hour or less101$101$414
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less95$22$91
Injection of additional new drug or substance into vein62$12$55
Blood draw (venipuncture)27$8$9
Office visit, established patient (20-29 min)25$64$280
Drug injection, under skin or into muscle24$11$53
New patient office visit, complex (60-74 min)16$178$673
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
15.2% high complexity
30.0% medium
54.8% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$465,495
Total received (2018-2024)
Avg $66,499/year across 7 years
Top 4% in TX for medical oncology
72
Companies
772
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$414,960 (89.1%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$40,445 (8.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,090 (2.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$94,440
2023
$117,938
2022
$78,692
2021
$42,951
2020
$33,623
2019
$34,412
2018
$63,439

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Gilead Sciences, Inc.
$199,696
Stemline Therapeutics Inc.
$83,268
Puma Biotechnology, Inc.
$61,907
Eisai Inc.
$29,557
AstraZeneca Pharmaceuticals LP
$28,637
EISAI INC.
$13,741
Novartis Pharmaceuticals Corporation
$13,416
R-Pharm US LLC
$7,513
PFIZER INC.
$5,676
NOVARTIS PHARMACEUTICALS CORPORATION
$5,108
Immunomedics, Inc.
$3,638
PUMA BIOTECHNOLOGY, INC.
$2,955
Heron Therapeutics, Inc.
$2,050
Daiichi Sankyo Inc.
$1,957
Foundation Medicine, Inc.
$739
Janssen Biotech, Inc.
$589
Amgen Inc.
$527
Celgene Corporation
$464
E.R. Squibb & Sons, L.L.C.
$446
Merck Sharp & Dohme LLC
$397
Genentech USA, Inc.
$307
Merck Sharp & Dohme Corporation
$245
GENZYME CORPORATION
$181
Myriad Genetic Laboratories, Inc.
$166
MorphoSys, US Inc.
$166
GlaxoSmithKline, LLC.
$159
Seagen Inc.
$152
TAIHO ONCOLOGY, INC.
$125
R-PHARM US LLC
$104
Astellas Pharma US Inc
$99
Janssen Pharmaceuticals, Inc
$85
Pharmacyclics LLC, an AbbVie Company
$81
Rigel Pharmaceuticals, Inc.
$73
Alexion Pharmaceuticals, Inc.
$72
Bayer Healthcare Pharmaceuticals Inc.
$61
Boston Scientific Corporation
$59
Boehringer Ingelheim Pharmaceuticals, Inc.
$58
Incyte Corporation
$57
Ipsen Biopharmaceuticals, Inc
$56
Tempus AI, Inc
$50
Pharmacyclics LLC, An AbbVie Company
$49
Lilly USA, LLC
$47
Takeda Pharmaceuticals U.S.A., Inc.
$47
ADC Therapeutics America, Inc.
$46
TerSera Therapeutics LLC
$45
BeiGene USA, Inc.
$45
JAZZ PHARMACEUTICALS INC.
$42
Adaptive Biotechnologies Corporation
$39
Kyowa Kirin, Inc.
$36
ABBVIE INC.
$35
SpringWorks Therapeutics, Inc.
$30
SANOFI-AVENTIS U.S. LLC
$29
Pharmacosmos Therapeutics Inc.
$26
AMAG Pharmaceuticals, Inc.
$25
Acceleron Pharma, Inc.
$24
PharmaEssentia USA Corporation
$24
Apellis Pharmaceuticals, Inc.
$23
Deciphera Pharmaceuticals Inc.
$23
AVEO Pharmaceuticals, Inc.
$22
LifeScan, Inc.
$20
Novo Nordisk Inc
$20
AbbVie Inc.
$19
Taiho Oncology, Inc.
$17
MACROGENICS, INC.
$17
CTI BioPharma Corp.
$16
Exelixis Inc.
$16
Secura Bio, Inc.
$15
Kite Pharma, Inc.
$14
Agios Pharmaceuticals, Inc.
$13
Regeneron Healthcare Solutions, Inc.
$12
Allergan Inc.
$12
Mylan Institutional Inc.
$11
Top 3 companies account for 74.1% of total payments
Associated products mentioned in payments ›
ADAKVEO · Alecensa · BESREMI · BLENREP · BOSULIF · BRUKINSA · CABLIVI · CABOMETYX · CALQUENCE · CINVANTI · COSELA · CYRAMZA · DARZALEX · ELITEK · ELZONRIS · ENHERTU · ENJAYMO · ERLEADA · Enhertu · FASLODEX · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID · Farydak · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · INLYTA · INREBIC · IXEMPRA · Imbruvica · Ixempra · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LINZESS · LONSURF · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lonsurf · MARGENZA · MEKINIST · MONJUVI · MONOFERRIC · MVASI · MYRISK · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · OGSIVEO · OJJAARA · OPDIVO · OPDUALAG · ORGOVYX · Ogivri · OneTouch · Onivyde · Orserdu · Ozempic · PADCEV · PIQRAY · PLUVICTO · PRALUENT · PROMACTA · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · Reblozyl · Revlimid · Rezlidhia · SANCUSO · SAR439859 · SCEMBLIX · SHINGRIX · SOMATULINE DEPOT · Stivarga · TABRECTA · TAGRISSO · TALZENNA · TASIGNA · TECENTRIQ · TIBSOVO · TUKYSA · Tavalisse · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VRAYLAR · Venclexta · Vonjo · WATCHMAN · XALKORI · XARELTO · XGEVA · XOSPATA · XT CDX · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · ZYTIGA · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in medical oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for medical oncology in TX.

Equivalent to $74,599 per 100 Medicare services performed
Looking for a medical oncology in Houston?
Compare medical oncologys in the Houston area by procedure volume, costs, and industry payment transparency.
Browse medical oncologys nearby

Geographic Context

Medical Oncologys within 10 mi
183
Per 100K population
3.8
County median income
$73,104
Nearest hospital
MEMORIAL HERMANN MEMORIAL CITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Alvarez is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (speaking/promotional, top 4%), with 18 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Alvarez experienced with complete blood count (cbc) with differential?
Based on Medicare claims data, Dr. Alvarez performed 147 complete blood count (cbc) with differential services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alvarez receive payments from pharmaceutical companies?
Yes. Dr. Alvarez received a total of $465,495 from 72 companies across 772 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alvarez's costs compare to other medical oncologys in Houston?
Dr. Alvarez's average Medicare payment per service is $50. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alvarez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →